RAPID MULTIPLEXED DETECTION OF CANCER RELATED PROTEINS

癌症相关蛋白的快速多重检测

• 批准号: 8356414
• 负责人: RICHARD ELLSON
• 金额: $ 19.99万
• 依托单位: GENALYTE, INC.
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-23 至 2012-06-23
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8356414
• 关键词: Antibodies; Biological Assay; Biological Markers; Biosensing Techniques; Cancer Detection; Coupled; Detection; Enzyme-Linked Immunosorbent Assay; Human; Label; Liquid substance; Malignant Neoplasms; Measures; Methodology; Modification; Peptides; Proteins; Qualifying; Quality Control; Reading; Sampling; Scanning; Silicon; Specimen; Technology; Testing; Time; Work; antigen binding; base; cancer proteomics; clinically relevant; commercialization; cost; instrument; instrumentation; photonics; prototype; sensor; usability

"Rapid Multiplexed Detection of Cancer Related Proteins" The contractor will utilize a multiplexed label-free platform developed by the contractor with potential to realize sensitive and high-throughput analysis of proteins in clinical samples. This technology will be used throughout the contract to demostrate how it can be used for cancer marker screening.

“癌症相关蛋白的快速多重检测”承包商将利用承包商开发的多重无标记平台，有可能实现临床样本中蛋白质的灵敏和高通量分析。该技术将在整个合同中使用，以演示如何将其用于癌症标志物筛查。